Cargando…

The NICE ADHD health technology assessment: A review and critique

BACKGROUND: Health technology assessments (HTAs) by the National Institute for Health and Clinical Excellence (NICE) enjoy high levels of international attention. The present analysis addresses NICE's appraisal of methylphenidate, atomoxetine and dexamphetamine for attention-deficit/hyperactivi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Schlander, Michael
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265261/ https://www.ncbi.nlm.nih.gov/pubmed/18197978 http://dx.doi.org/10.1186/1753-2000-2-1

Ejemplares similares

Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence
por: Schlander, Michael
Publicado: (2007)

Health technology assessment (HTA) and economic evaluation: efficiency or fairness first
por: Richardson, Jeff, et al.
Publicado: (2018)

The impact of rarity in NICE’s health technology appraisals
por: Clarke, Sophie, et al.
Publicado: (2021)

The social and cultural construction of psychiatric knowledge: an analysis of NICE guidelines on depression and ADHD
por: Moncrieff, Joanna, et al.
Publicado: (2013)

CERN Technology on display in Nice
Publicado: (2000)

CERN Technology on Display in Nice
Publicado: (2000)

Decision making in NICE single technological appraisals: How does NICE incorporate patient perspectives?
por: Hashem, Ferhana, et al.
Publicado: (2017)

Real-world data from expanded access programmes in health technology assessments: a review of NICE technology appraisals
por: Polak, Tobias B, et al.
Publicado: (2022)

NICE consulting on methods used for health technology evaluation
Publicado: (2020)

HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Schlander, Michael
Publicado: (2020)

When Does NICE Recommend the Use of Health Technologies Within a Programme of Evidence Development?: A Systematic Review of NICE Guidance
por: Longworth, Louise, et al.
Publicado: (2013)

Monitoring of ADHD Medication: Are We in Line With NICE Guidelines? a Closed Loop Audit
por: Langan, Clare
Publicado: (2022)

Review of the role of NICE in promoting the adoption of innovative cardiac technologies
por: Groves, Peter H, et al.
Publicado: (2018)

NICE Medical Technologies Guidance: A Novel and Rigorous Methodology to Address a New Health Technology Assessment Challenge
por: Campbell, Bruce, et al.
Publicado: (2012)

Chile's Neoliberal Health Reform: An Assessment and a Critique
por: Unger, Jean-Pierre, et al.
Publicado: (2008)

Specialist adult ADHD clinics in East Anglia: service evaluation and audit of NICE guideline compliance(†)
por: Magon, Rakesh Kumar, et al.
Publicado: (2015)

Medication Initiation in Children Newly Diagnosed With ADHD, Measured Against NICE Guideline NG87
por: McWilliams, Emma, et al.
Publicado: (2023)

Flexibility in assessment of rare disease technologies via NICE's single technology appraisal route: a thematic analysis
por: Hale, George, et al.
Publicado: (2023)

Weighty: NICE's Not-So-Nice Words
por: Lozano-Sufrategui, Lorena, et al.
Publicado: (2016)

The use of UK primary care databases in health technology assessments carried out by the National Institute for health and care excellence (NICE)
por: Leahy, Thomas P., et al.
Publicado: (2020)

Critique
Publicado: (1953)

The Critique
Publicado: (1898)

It’s not evidence, it’s insight: bringing patients’ perspectives into health technology appraisal at NICE
por: Staley, Kristina, et al.
Publicado: (2016)

NICE medical technologies guidance: aims for clinical practice
por: Campbell, Bruce
Publicado: (2013)

P07-10 Nice acti'santé: Let’s move for health in Nice
por: Falzon, Charlène, et al.
Publicado: (2022)

Nice
por: Kunkler, Ian
Publicado: (1999)

A review and critique of assessment instruments for patients with persistent pain
por: Grimmer-Somers, Karen, et al.
Publicado: (2009)

NICE and Fair? Health Technology Assessment Policy Under the UK’s National Institute for Health and Care Excellence, 1999–2018
por: Charlton, Victoria
Publicado: (2019)

Critiquing the Critique: Resisting Commonplace Criticisms of Antidepressants in Online Platforms
por: Sthamann, Erin, et al.
Publicado: (2021)

Writing, reading, and critiquing reviews
por: Archibald, Douglas, et al.
Publicado: (2021)

NICE technology appraisals: working with multiple levels of uncertainty and the potential for bias
por: Brown, Patrick, et al.
Publicado: (2011)

Determining Value in Health Technology Assessment: Stay the Course or Tack Away?
por: Caro, J. Jaime, et al.
Publicado: (2018)

Adult ADHD clinics in north Wales - case load prevalance & compliance with nice guidelines (quality evaluation project)
por: Raja, Jawad, et al.
Publicado: (2021)

‘Toning’ up hypotonia assessment: A proposal and critique
por: Govender, Pragashnie, et al.
Publicado: (2016)

Suicide Risk Assessments: A Scientific and Ethical Critique
por: Smith, Mike
Publicado: (2022)

A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process
por: Walton, M. J., et al.
Publicado: (2019)

NICE: an evolving institution
por: Rawlins, Michael
Publicado: (2013)

Biologic agents for rheumatoid arthritis—negotiating the NICE technology appraisals
por: Kiely, Patrick D. W., et al.
Publicado: (2012)

Health Technology Assessment capacity development in low- and middle-income countries: Experiences from the international units of HITAP and NICE
por: Tantivess, Sripen, et al.
Publicado: (2017)

Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process
por: Kaltenthaler, Eva, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_frniji4ph9oil5ilq69on9rgd0